• Multi-year supply agreement for radium-226 processing and purification• Collaboration will work to provideAc-225 for clinical trials and commercial supply
Each year, BWXT Medical submits a comprehensive Annual Compliance Report (ACR) to the Canadian Nuclear Safety Commission (CNSC) for its
(OTTAWA, Ontario – June 7, 2024) – BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S.
BWXT Medical conducts community surveys to obtain feedback on its public information program, including its strengths and key areas for
Agreement Furthers BWXT Medical’s Position as a Global Leader in Actinium Supply Collaboration Enables Fusion to Produce High Purity Actinium-225
(Ottawa, Ontario – February 1, 2023) – Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG)